Name: Latest research reports of Ajanta Pharma Ltd. authored by BOB Capital Markets Ltd. and published by - Trendlyne research reports.
Item: Ajanta Pharma Ltd.
Rating: 5
Author: BOB Capital Markets Ltd.

Ajanta Pharma Ltd.

NSE: AJANTPHARM | BSE: 532331 | ISIN: INE031B01049 | Industry: Pharmaceuticals
| Mid-range Performer

2579.1000 7.10 (0.28%)

NSE Sep 12, 2025 15:31 PM

Volume: 58,267

Ajanta Pharma Ltd.

31 Jul 2021

2579.10

0.28%

Ajanta Pharma (BUY): Strong earnings growth; reiterate BUY

Buy: Ajanta Pharma Ltd.

Target

BOB Capital Markets Ltd.

Q1 PAT robust at Rs 1.7bn, up 17% YoY. Sales grew 12% YoY while EBITDA declined 2%

Number of FII/FPI investors decreased from 385 to 371 in Jun 2025 qtr